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During apoptosis, caspases cleave cellular substrates to break down and package the apoptotic 
cell for removal. Reporting in Cell, Mahrus et al. (2008) and Dix et al. (2008) use new approaches 
that identify hundreds of previously unrecognized caspase substrates, many of which appear to 
produce polypeptide fragments with potentially new functional activities.Caspases (cysteine-dependent aspar-
tate-directed proteases) are the chief 
executioners of apoptotic cell death, 
transforming intact cells into parceled 
remnants suitable for phagocytic inges-
tion. Although dismantling of cells by 
caspases could, in theory, result from 
indiscriminate proteolysis, the packag-
ing of apoptotic cells might also reflect 
the selective proteolysis of precise cel-
lular substrates. Distinguishing between 
these possibilities requires a compre-
hensive identification and functional 
analysis of caspase substrates. Many 
caspase substrates have been identified 
either through large-scale in vitro cleav-
age of peptide libraries, which provides 
no information about physiological rel-
evance, or through analysis of individual 
proteins by gel electrophoresis, which is 
low throughput and often relies on the 
availability of specific antibodies to track 
proteolytic fragments. Two new stud-
ies in Cell (Dix et al., 2008; Mahrus et 
al., 2008) address deficiencies in these 
approaches by developing proteomics-
based platforms that enable large-scale 
profiling of proteolytic events.
The two groups each use unique 
methodologies to analyze caspase-
mediated proteolysis in apoptotic Jurkat 
T cells. Dix et al. (2008) developed PRO-
TOMAP, a platform that combines gel 
electrophoresis (SDS-PAGE) with mass 
spectrometry (shotgun LC-MS/MS) to 
visually compare the size, topography, 
and abundance of proteins in control 
cells versus cells treated with stauro-
sporine, a kinase inhibitor that induces 
apoptosis. This methodology offers the 
unprecedented ability to detect all cleav-
age fragments without access to spe-
cific immunological reagents. Mahrus 
et al. (2008) present a technology that 
captures N-terminal peptides produced 
during etoposide-induced apoptosis by 
cleverly taking advantage of biotinylation 
of α-amines (and not lysine ε-amines) 
by subtiligase. This approach allows 
selective N-terminal labeling (including 
de novo N termini produced by cas-
pase cleavage), capture of labeled pep-
tides on an avidin resin, and LC-MS/MS 
analysis to determine the precise sites of 
proteolytic cleavage. Such strategies for 
comprehensive investigation of prote-
olytic events provide an important prec-
edent for the analysis of other types of 
proteolysis and of caspase-dependent 
proteolysis induced by different stimuli 
or in different cell types.
Despite their different methodologies, 
both studies uncovered hundreds of pre-
viously unreported caspase substrates. 
With Dix et al. (2008) documenting 170 
new substrates and Mahrus et al. (2008) 
finding 240 new substrates, these data 
highlight our incomplete knowledge of 
caspase-mediated proteolysis. Indeed, 
Lüthi and Martin (2007) recently com-
piled every caspase substrate published 
to date in a searchable database (CAS-
BAH), with substrate numbers upwards 
of 400. Given that the lists generated by 
CASBAH, Dix et al., and Mahrus et al. 
only have minimal overlap (Figure 1A), it 
is likely that the list of substrates will only 
continue to grow. Interestingly, quantita-
tion of cleavage events in the Dix et al. 
report suggest that previous studies may 
have been limited by low sensitivity in 
that only the more abundant substrates 
in the PROTOMAP data set had been 
shown previously to be cleaved during 
apoptosis.
Given the vast number of substrates, 
are caspases acting indiscriminately, or 
is there some method to the madness? 
Certain substrates are known to be cru-
cial for affecting typical apoptotic mor-
phology, such as membrane blebbing 
induced by cleavage of the Rho-asso-
ciated kinase ROCK1 and DNA frag-
mentation induced by cleavage of the 
endonuclease CAD/DFF40 (Coleman et 
al., 2001; Woo et al., 2004). But are these 
examples the exception or the rule? 
Intriguing data from each study suggest 
that an active caspase is not a haphazard 
“Pac-Man” but rather a purposeful and 
incisive surgeon. Perhaps most surpris-
ing is the observation by Mahrus et al. 
that caspases appear to target multiple 
proteins within single protein complexes 
or biochemical pathways. Their analy-
sis most strongly implicates proteins 
involved in the regulation of transcription 
as caspase targets but also identifies 
subnetworks of substrates in 11 other 
pathways, including those that regulate 
DNA repair and block apoptosis. These 
data suggest that caspases may coordi-
nately control specific biochemical path-
ways or signaling networks.
A second surprising result, reported 
by Dix et al., suggests that more than 
one-third of proteolytic fragments gen-
erated by caspase cleavage are stable 
for at least 4 hr (in cells that died within 6 
hr after apoptotic stimulation). This is in 
contrast to the notion that cleaved cas-
pase substrates are rapidly degraded. 
For example, Ditzel et al. (2003) reported 
that caspase-mediated cleavage of 
DIAP1, a Drosophila inhibitor of apopto-
sis protein (IAP), generates an unstable 
N-degron that quickly undergoes com-
plete degradation via the N-end rule 
pathway. Although the global analysis of 
caspase substrates suggests that pro-
duction of stable fragments may be fre-
quent, caspase cleavage-induced deg-720 Cell 134, September 5, 2008 ©2008 Elsevier Inc.
figure 1. Caspase substrates and Potential functions of their Cleavage Products
(A) Depicted is the overlap between the caspase substrates in apoptotic Jurkat T cells identified by Dix 
et al. (2008) and Mahrus et al. (2008) and the previously reported human caspase substrates as compiled 
in the CASBAH database (Lüthi and Martin, 2007). The total number of substrates reported in each study 
is indicated in parentheses.
(B) Caspase-mediated cleavage of a cellular substrate resulting in separation of functional domains could 
lead to either constitutive activity of one of the proteolytic fragments (left) or to loss of function of the 
substrate (right). Depicted is the separation of a kinase domain from its regulatory domain, which allows 
for unchecked phosphorylation of target proteins (left). Conversely, separation of a DNA binding domain 
from a coactivator interaction domain within a transcription factor would prevent coactivator recruitment 
to the DNA, thereby hindering transcriptional induction (right).radation of antiapoptotic proteins (such 
as DIAP1) makes sense as a means for 
“releasing the brakes” on apoptosis. 
Future mining of the PROTOMAP data 
might query whether cleavage of other 
antiapoptotic substrates produces 
unstable fragments.
Even more interesting, Dix et al. 
noticed that a number of the persistent 
peptide fragments mapped to distinct, 
stably folded protein domains, leading 
them to speculate that caspase-medi-
ated proteolysis yields a class of effec-
tor protein fragments with new activities. 
Mahrus et al. were similarly interested in 
whether caspases might preferentially 
cleave substrates between functional 
domains, but their analysis demon-
strated an even split of sites within or 
between domains. That said, data from 
both groups support the concept that 
a substantial portion of caspase sub-
strates are cleaved into domain-contain-
ing fragments. As to the purpose of such 
cleavage events, Mahrus et al. speculate 
that physical separation of functional 
domains can lead to protein inactivation 
(or perhaps production of dominant-
negative fragments). Given that Dix et al. 
predict cleavage-induced activation of 
domain-containing fragments, how does 
one resolve this apparent discrepancy? Cell 134, SPerhaps the simple answer is that both 
models are correct, depending on the 
individual substrate in question (Figure 
1B). It has long been appreciated that 
cleavage of kinases can release consti-
tutively active domains (such as cleaved 
HPK1, a modulator of the JNK pathway), 
whereas cleavage of other substrates, 
such as poly (ADP-ribose) polymerase 
(PARP), is associated with loss of func-
tion (Chen et al., 1999; D’Amours et al., 
2001).
The techniques described in these 
new reports provide powerful methods 
for global analysis of caspase-medi-
ated proteolysis. Collectively, the data 
suggest that dismantling the apoptotic 
cell is more akin to folding a tent after 
careful removal of the pegs than to 
gathering and disposing of indiscrimi-
nately destroyed debris after an explo-
sion. Caspases selectively target cer-
tain biochemical pathways, generating 
a unique set of stable protein fragments 
possessing new functionality within 
the dying cell. Although an impressive 
start, the work leaves much left to do. 
Given the large number of substrates 
identified, one of the most daunting but 
important next steps will be to verify 
each putative caspase substrate and 
determine what, if any, functional sig-
nificance it may have in mediating the 
execution of apoptosis.
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